Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02162056

Acronym

CSI-Ulm-BVS

Enrollment

326

Registered

2014-06-12

Start date

2013-11-30

Completion date

2018-12-31

Last updated

2020-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Coronary Artery Disease, Ischemic Heart Disease, Stable Angina, Unstable Angina

Brief summary

To evaluate the safety, performance and efficacy of the bioresorbable vascular scaffold (BVS) system in patients with coronary artery disease

Detailed description

Patients with coronary artery disease receive bioabsorbable vascular scaffolds. Patients are clinically followed during a period of 10 years.

Interventions

DEVICEuse of bioresorbable vascular scaffolds

Implantation of bioresorbable vascular scaffolds for coronary artery disease.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* coronary artery disease * implantation of at least one bioresorbable vascular scaffold

Exclusion criteria

* no written informed consent

Design outcomes

Primary

Measure	Time frame
Major Adverse Cardiac Events	10 years

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026